Healthcare and Life Science
2024 Corazon's Charity of the Year
Corazon Health is delighted to announce that EACH (East Anglia's Children's Hospices) has been chosen as their 2024 Charity of The Year, following a selection process that included a vote by employees. The charity supports families and provides care for children and young peop...
Optibrium launches a metabolism prediction software platform tailored to DMPK scientists
Semeta™ offers high sensitivity and superior precision for the prediction of Phase I and II metabolic routes, sites, products and liabilities in early drug discovery ...
Pioneering cataract test for babies has worldwide potential
Researchers are calling on new parents to back a national study to help prevent the most common cause of preventable childhood blindness, congenital cataracts. ...
Jon Hume joins Cuttsy+Cuttsy as New Commercial Director
Cuttsy+Cuttsy is excited to announce the appointment of Jon Hume as Commercial Director, effective 1st March 2024. ...
TR Events & Catering Announces George Nolan as New Head of Sales
TR Events & Catering, a leading multi-service event management provider in Cambridgeshire and Suffolk, is thrilled to announce the appointment of George Nolan as the new Head of Sales. This appointment is a significant milestone for the company, signalling its continued growth and e...
Butterfly and moth genomes mostly unchanged despite 250 million years of evolution
Comparison of over 200 high-quality butterfly and moth genomes reveals key insights into their biology, evolution and diversification over the last 250 million years, as well as clues for conservation. ...
SPT Labtech continues to support UKHSA genomics surveillance project to bolster global health security
Cambridge – SPT Labtech, a global leader in the design, development and manufacture of automated instrumentation and consumables for life science applications, continues its partnership with the UK Health Security Agency (UKHSA) to advance global genomics surveillance. SPT Lab...
Drug trial brings hope to Parkinson’s patients
Cambridge researchers and Addenbrooke’s Hospital patients are joining forces to trial a new drug aimed at treating Parkinson’s disease. ...
Launching evolue - hello World
Hello World We are excited to announce the official launch of evolue, a dynamic agile consultancy, that is committed to empowering organisations and individuals in navigating the ever-changing landscape of today's world. About Us: ...
MIP Discovery closes £7M Series A financing to drive commercialization in cell and gene therapy space
Company’s synthetic affinity reagents are antibody alternatives designed to advance the speed, safety, and efficiency of manufacturing at scale, making advanced therapies more accessible to patients. Investment led by Mercia Ventures, with Calculus Capital and Angel investors also pa...